Stocks-GILD-Gilead Sciences Inc

GILD Gilead Sciences Inc

78.72 0.91 (1.17%)
Försenade priser från NASDAQ, i USD Marknaden är öppen
Investera
Stocks-GILD-Gilead Sciences Inc
GILD Gilead Sciences Inc
Investera

Prestation

0% Senaste veckan
Börsvärde
97.04B
Dagens intervall
77.46
-
78.80
52 veckors intervall
57.11
-
89.47
Volym (3M)
6.17M
Pris-vinstförhållande
21.38
Intäkt
27.09B

Senaste nytt om Gilead Sciences Inc

Visa alla
CAR T Cell Therapy Market to See Rapid Growth in 2023 – 2030 | Novartis AG, Amgen Inc., Gilead Sciences, IncCAR T Cell Therapy Market to See Rapid Growth in 2023 – 2030 | Novartis AG, Amgen Inc., Gilead Sciences, IncEIN News Healthcareca 7 timmar sedanGilead Sciences' Debt OverviewGilead Sciences' Debt OverviewBenzingaca 24 timmar sedanGilead Sciences: Groups Around the World Work to Eliminate Hepatitis C by Meeting People Where They AreGilead Sciences: Groups Around the World Work to Eliminate Hepatitis C by Meeting People Where They AreFinanz Nachrichtenen dag sedan
Fastnålat inlägg
eToro Team
eToro
ca 6 timmar sedan
📰 EXTRA EXTRA…New charts arrived on eToro! Today we would like to give an official welcome to our new charts, in partnership with TradingView, one of the market leaders in charting and analysis tools. Yes, we know! You have already noticed the change but now we want to share with you what this complete... Visa mer Översätt
Gilla-markering KommenteraDela
Visa fler kommentarer2 av 25
null
.
Diskussioner om Topp
DeepNews
eToro
6 dagar sedan
$GILD (Gilead Sciences Inc) Here’s Why Gilead Sciences (GILD) Outperformed in Q4 Ariel Investments, an investment management company, released its “Ariel Global Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. finance.yahoo.com/news/why-gilead-sciences-gild-outperformed-113050409.html Översätt
Here’s Why Gilead Sciences (GILD) Outperformed in Q4
finance.yahoo.com
Ariel Investments, an investment management company, released its “Ariel Global Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the Ariel Global Composite delivered a 10.72% gross of fees compared to a +9.76% return for the primary MSCI ACWI Index and a +14.21% gain for the MSCI ACWI […]
Gilla-markering KommenteraDela
Dimitrios Bakolas
Grekland
10 dagar sedan
Gilla-markering KommenteraDela
Apostolos Paschalidis
Grekland
11 dagar sedan
Redigerad
Hello dear followers and copiers WEEKLY UPDATE 12/03/2023 First of all welcome to the new copiers, followers and many thanks for your trust. Estimated Dividend Yield 4.21% AFT(After Foreign Taxes)(USA 30%) Target 5.00% STATS: Revenue YTD 1.09% (0.53% Dividend AFT) Revenue 2022 ... Visa mer Översätt
Gilla-markering KommenteraDela
null
.
DeepNews
eToro
14 dagar sedan
$GILD (Gilead Sciences Inc) Gilead Sciences (GILD) Stock Moves -1.55%: What You Should Know In the latest trading session, Gilead Sciences (GILD) closed at $78.96, marking a -1.55% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.85%. www.msn.com/en-us/money/topstocks/gilead-sciences-gild-stock-moves-155-what-you-should-know/ar-AA18r9gx Översätt
Gilead Sciences (GILD) Stock Moves -1.55%: What You Should Know
www.msn.com
In the latest trading session, Gilead Sciences (GILD) closed at $78.96, marking a -1.55% move from the previous day. This move was narrower than the S&P 500's daily loss of 1.85%. Elsewhere, the Dow lost 1.66%, while the tech-heavy Nasdaq lost 10.91%. Heading into today, shares of the HIV and hepatitis C drugmaker had lost 6.39% over the past month, lagging the Medical sector's loss of 3.72% and the S&P 500's loss of 2.85% in that time. Gilead...
Gilla-markering KommenteraDela
DeepNews
eToro
19 dagar sedan
$GILD (Gilead Sciences Inc) Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know Gilead Sciences (GILD) closed at $81.07 in the latest trading session, marking a +1.82% move from the prior day. This change outpaced the S&P 500's 1.62% gain on the day. www.msn.com/en-us/money/topstocks/gilead-sciences-gild-outpaces-stock-market-gains-what-you-should-know/ar-AA18cnDM Översätt
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
www.msn.com
Gilead Sciences (GILD) closed at $81.07 in the latest trading session, marking a +1.82% move from the prior day. This change outpaced the S&P 500's 1.62% gain on the day. Meanwhile, the Dow gained 1.17%, and the Nasdaq, a tech-heavy index, added 12.91%. Heading into today, shares of the HIV and hepatitis C drugmaker had lost 2.17% over the past month, outpacing the Medical sector's loss of 3.29% and the S&P 500's loss of 4.54% in that time....
Gilla-markering KommenteraDela

Om Gilead Sciences Inc

Gilead Sciences Inc (GILD) är ett amerikanskt biofarmaceutiskt företag. Företaget fokuserar på forskning och utveckling av antivirala läkemedel som används vid behandling av HIV, hepatit B, hepatit C och influensa. Bolaget grundades 22 juni 1987 och har sitt huvudkontor i Foster City, Kalifornien, USA. Gilead Sciences Inc är noterade på NASDAQ under GILD. Följ GILD på eToro.
17K
Anställda
Foster City, California, US
Huvudkontor
1987
Grundad
Daniel P. O'Day, MBA
VD
Show More
Medicinsk teknikNASDAQ

Kommande intäkter

27
APR
RAPPORTER
Gilead Sciences IncResultatrapport för Q 1 2023 förväntas släppas efter att marknaden öppnat

Analytikerprognos

Konsensus
Måttligt köp
Prismål
92.50
Baserat på  4 analytiker som täckte GILD 

ESG: En ny källa till insikt

Vad är en ESG-poäng?
Detta nummer är ett mått på ett företags exponering för miljömässiga, sociala och styrningsrisker. Påverkande faktorer inkluderar energieffektivitet, säkerhet, socialpolitik och mer. Läs mer
Drivs av ESG Book
Få insikt i ett företags hållbarhet med hjälp av ESG-poäng (miljö, socialt ansvar och bolagsstyrning).
0
100
53
Medium
Industri 
Genomsnitt 45 
72
Miljö
67
Socialt ansvar
36
Bolagsstyrning

Folk köpte också